The Rise of the Fetal Monitoring Industry: Enhancing Pregnancy Care

In the last few years, there has been a rapid increase within the fetal monitoring market as preterm births have become more common in recent decades. According to the World Health Organization's 2018 fact sheet, approximately 15 million newborns are born 37 weeks before pregnancy all over the world, and the preterm birth rate is estimated to be among 5% to 18% of all newborns in 184 nations.

It has been proven that premature babies are prone to developing sicknesses and infections. Consequently, those newborns are monitored through the usage of monitoring gadgets. As a result, the demand for tracking equipment and devices has increased. Hence, the development of fetal monitoring structures has been initiated. 

Fetal monitoring is a diagnostic device used to display the movement and heart rate of the unborn baby, as well as the uterine contractions of the mother. It is a primary tool used to reveal the fetus's fitness and the development of labor. In scientific terms, it is a clinical method used to evaluate the health of the unborn baby to make certain a secure delivery of the baby. Additionally, it is used to reveal the mental retardation of the unborn baby, chronic lung illnesses, hypothermia, and newborn disorders, as well as vision, hearing issues, and jaundice.  

According to a recent report published by Allied Market Research, the fetal monitoring market is expected to display a miraculous CAGR of 6.2% during the projection period. 

Latest trends in the fetal monitoring market: 

The fetal monitoring market has seen several trends in recent years. One of the most notable trends is the shift to non-intrusive and wireless fetal monitoring technologies. This way pregnant women will be capable of monitoring their infants greater conveniently and without difficulty, and healthcare specialists may be able to get actual-time information greater effectively.

Another trend is fetal monitoring systems are more and more being incorporated with EHR (Electronic Health Record) and Telemedicine systems, allowing remote tracking and consultation. This is mainly relevant in rural and underserved regions, where access to healthcare services may be limited.

In addition, there is a great emphasis on fetal monitoring device accuracy and reliability. Advanced algorithms and machine learning techniques are being developed to improve monitoring data interpretation and provide more precise evaluations of fetal health. 

Key developments in the fetal monitoring industry: 

Industry leaders have adopted avant-garde strategies like new alliances, technological innovations, and new product launches to strengthen their position in the market. For example, Pulsenmore and GE Healthcare signed an agreement in May 2022 to accelerate the take-up of their home care ultrasound products and to support their efforts to obtain US FDA approval and commercialization. 

Another key development by ArchiMed Group, a subsidiary of ArchiMed (France), acquired the US-based Natus in April 2022, intending to expand the scope and range of Natus’ market-dominant products, thereby reinforcing the emphasis on research and development and the acquisition of complementary businesses. 

Moreover, in March 2021, the Chinese company CONTEC Medical Systems Inc. (China) released the CMS1700B color Doppler ultrasonic diagnostic system, which is primarily designed for the diagnosis of issues in the abdominal, cardiac, peripheral vessels, breasts, obstetrics, gynecological, small organ, urological, muscle, excretion, and pediatric conditions. 

To conclude, the fetal monitoring market is predicted to experience significant increase and innovation in the coming years due to its persistent contribution to the development of maternal and fetal health outcomes. Advancements in generation and an elevated cognizance of personalized medicine are anticipated to result in further development and innovation in this field.

Related Post